Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Amit Sanyal, MD: A Clinician’s Perspective

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Advertisement

Advertisement




May
06
Today In Oncology
USPSTF Issues Final Recommendation Statement on Screening for Breast Cancer
Relapsed or Refractory CD7-Positive Leukemia or Lymphoma CAR T-Cell Therapy Plus HSCT Without GVHD Prophylaxis
Premastectomy Radiotherapy, Surgery, and Immediate Breast Reconstruction
Liposomal Irinotecan vs Topotecan in Relapsed Small Cell Lung Cancer
Smoking Cessation Regimens: Does Dose of Therapy Matter?
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside